Stocks and Investing Stocks and Investing
Wed, February 10, 2016
[ 12:00 AM ] - WOPRAI
Jeff Van Rhee Upgraded (AKAM) to Strong Buy on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Sameet Sinha Upgraded (AKAM) to Strong Buy on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Ken Herbert Upgraded (TDG) to Buy on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Steven Ashley Initiated (TEAM) at Hold and Held Target at $23 on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Mark Moskowitz Maintained (CDW) at Buy with Decreased Target to $47 on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Saket Kalia Maintained (VRNS) at Hold with Decreased Target to $5.67 on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Neil Mehta Maintained (VLO) at Strong Buy on, Feb 10th, 2016
[ 12:00 AM ] - WOPRAI
Bryan Keane Maintained (WU) at Hold with Decreased Target to $19 on, Feb 10th, 2016
Tue, February 9, 2016
[ 12:00 AM ] - WOPRAI
Brian Nowak Maintained (YELP) at Hold with Decreased Target to $19 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Colin Sebastian Maintained (YELP) at Hold with Decreased Target to $19 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Eric Sheridan Maintained (YELP) at Hold with Decreased Target to $17 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Matthew Thornton Maintained (YELP) at Strong Buy with Decreased Target to $22 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Kip Paulson Maintained (YELP) at Strong Buy with Decreased Target to $38 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Alex Kramm Maintained (VIRT) at Strong Buy with Decreased Target to $24 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Ryan Todd Maintained (VLO) at Strong Buy with Decreased Target to $87 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brandon Rolle Downgraded (WGO) to Hold on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Seth Sigman Maintained (AZO) at Buy with Increased Target to $750 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
George Bahamondes Maintained (AGNC) at Hold with Decreased Target to $20 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (TROW) at Strong Buy with Decreased Target to $72 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Johnson Maintained (TSLA) at Sell with Decreased Target to $11 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (SXT) at Buy with Decreased Target to $66 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (STT) at Hold with Decreased Target to $52 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (CBOE) at Hold with Increased Target to $66 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Stephen Anderson Initiated (CAKE) at Strong Buy and Held Target at $57 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (BLK) at Strong Buy with Decreased Target to $163 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Domingos Falavina Maintained (BMA) at Hold with Increased Target to $69 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (BK) at Strong Buy with Decreased Target to $41 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Paul Hissey Initiated (BHP) at Hold and Held Target at $15 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Jessica Fye Downgraded (BCRX) to Hold and Held Target at $5 on, Feb 9th, 2016
[ 12:00 AM ] - WOPRAI
Maury Raycroft Downgraded (BCRX) to Strong Buy and Decreased Target to $2 on, Feb 9th, 2016

Maury Raycroft Downgraded (BCRX) to Strong Buy and Decreased Target to $2 on, Feb 9th, 2016


Published on 2024-10-25 11:28:32 - WOPRAI, Maury Raycroft
  Print publication without navigation


Maury Raycroft of Jefferies, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Decreased Target from $14 to $2 on, Feb 9th, 2016.

Maury has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury

  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015
Contributing Sources